Britannia Life Sciences (FRA:L020) ROCE %: 45.88% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:L020 Britannia Life Sciences Inc FRA:L020
35 GF Score
Price €0.03
! 5 Warning Signs
View Full Analysis

What is Britannia Life Sciences ROCE %?

Britannia Life Sciences FRA:L020 35 ROCE % is 45.88% as of Mar. 2026. GuruFocus rates FRA:L020 with a GF Score™ of 35/100. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Britannia Life Sciences's annualized ROCE % for the quarter that ended in Mar. 2026 was 45.88%.

Britannia Life Sciences  (FRA:L020) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Britannia Life Sciences ROCE % Related Terms

Britannia Life Sciences ROCE % Historical Data

* Premium members only.

The historical data trend for Britannia Life Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Britannia Life Sciences ROCE % Chart

Britannia Life Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial -94.23 41.48 -39.09 -43.75 93.40

Britannia Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -81.75 -35.80 -22.04 408.11 45.88
FRA:L020
35GF Score
Britannia Life Sciences Inc FRA:L020
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Britannia Life Sciences ROCE % Calculation

Britannia Life Sciences's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=8.579/( ( (7.481 - 2.354) + (15.047 - 1.804) )/ 2 )
=8.579/( (5.127+13.243)/ 2 )
=8.579/9.185
=93.40 %

Britannia Life Sciences's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=5.492/( ( (13.658 - 2.96) + (15.047 - 1.804) )/ 2 )
=5.492/( ( 10.698 + 13.243 )/ 2 )
=5.492/11.9705
=45.88 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 45.88% mean?
Britannia Life Sciences (FRA:L020) has a ROCE % of 45.88% as of Mar. 2026.
Is Britannia Life Sciences' ROCE % too high?
Britannia Life Sciences' current ROCE % is 45.88%. Overall, Britannia Life Sciences has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Britannia Life Sciences' ROCE % compare to VRTX and REGN?
Britannia Life Sciences' ROCE % of 45.88% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Britannia Life Sciences's current ROCE % is 45.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Britannia Life Sciences stock overvalued right now?
Britannia Life Sciences (FRA:L020) has a current ROCE % of 45.88%. The current ROCE % is 45.88%. Britannia Life Sciences' overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Britannia Life Sciences (FRA:L020), the current ROCE % is 45.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Britannia Life Sciences Business Description

Other Exchanges BLAB:Canada
Address 120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Britannia Life Sciences Inc provides product testing, safety assessment, and manufacturing services to the cosmetic and consumer packaged goods industries in the United Kingdom and globally.
35GF Score

Get the complete analysis for FRA:L020

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price